Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1974-11-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
291-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4605318-Antineoplastic Agents,
pubmed-meshheading:4605318-Clinical Trials as Topic,
pubmed-meshheading:4605318-Humans,
pubmed-meshheading:4605318-Neoplasm Metastasis,
pubmed-meshheading:4605318-Neoplasms,
pubmed-meshheading:4605318-Orosomucoid,
pubmed-meshheading:4605318-Prognosis
|
pubmed:year |
1974
|
pubmed:articleTitle |
The prognostic significance of serial seromucoid analyses in patients with cancer.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|